Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Propanc Biopharma Inc (PPCB) had Income from Continuous Operations of $-6.36M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-6.36M |
|
-- |
|
-- |
|
$6.40M |
|
$-6.40M |
|
$0.04M |
|
$-6.36M |
|
$-6.36M |
|
$-6.36M |
|
|
Income from Continuous Operations |
$-6.36M |
$-6.36M |
|
$-6.36M |
|
$-6.40M |
|
$-6.40M |
|
0.90M |
|
0.90M |
|
$-7.00 |
|
$-7.00 |
|
| Balance Sheet Financials | |
$8.22M |
|
$0.00M |
|
$6.11M |
|
$14.33M |
|
$3.48M |
|
-- |
|
$1.03M |
|
$4.51M |
|
$9.83M |
|
$9.83M |
|
$9.83M |
|
0.87M |
|
| Cash Flow Statement Financials | |
$-4.08M |
|
$-0.00M |
|
$4.47M |
|
$0.01M |
|
$0.44M |
|
$0.43M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.37 |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.09M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-64.72% |
|
-64.72% |
|
-44.37% |
|
-64.72% |
|
$11.24 |
|
$-4.55 |
|
$-4.55 |
|